Cetrorelix pamoate, a long-acting intramuscular injection, is currently in three Phase III trials involving more than 1,600 patients with symptomatic benign prostatic hyperplasia (BPH) in Canada, the US
NovaBay said that the study of NVC-422, which is a synthetic bioequivalent form of the most effective and rapidly acting anti-infective molecules produced by white blood cells, revealed
Under the terms of the agreement, Watson will pay Elan $18 million in full settlement of all disputes related to Watson’s development, manufacturing, marketing and sale of its
The randomized, double-blinded, vehicle-controlled study completed in late 2008 enrolled 186 patients with acne and consisted of twice daily topical applications of ASC-J9 cream for 12 weeks to
In this new position, Mr Evashenk will assist in defining developmental strategy, guiding clinical protocol design and study conduct, and managing risk assessment. He will report to Pamela
For the year 2008, Noven reported a net income of $21.4 million, or $0.87 per diluted share, compared to a net loss of $45.4 million, or $1.84 per
Sanofi-aventis has signed an agreement with the Mexican authorities to build a E100m facility to manufacture influenza vaccine in Mexico. The agreement was signed by Birmex’ (Laboratorio de
Yet, people on both sides of the stem cell debate say Obama’s announcement could lead to a reconsideration of the ban on Capitol Hill, an idea so controversial
Hana Biosciences has announced new positive preliminary efficacy results from a planned interim analysis of the ongoing pivotal rALLy clinical trial evaluating Marqibo for the treatment of adult
Abraxis BioScience, a fully integrated biotechnology company, has reported a net loss of $181.9m, or $4.54 per share, for the fourth quarter of 2008, compared with a net
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.